X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32238) 32238
Newsletter (39) 39
Dissertation (36) 36
Book Chapter (32) 32
Magazine Article (26) 26
Conference Proceeding (13) 13
Government Document (11) 11
Newspaper Article (11) 11
Publication (8) 8
Book / eBook (3) 3
Book Review (2) 2
Web Resource (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24948) 24948
doxorubicin - administration & dosage (22400) 22400
science & technology (19767) 19767
life sciences & biomedicine (17470) 17470
female (16621) 16621
male (13457) 13457
antineoplastic combined chemotherapy protocols - therapeutic use (12649) 12649
middle aged (11273) 11273
adult (9419) 9419
oncology (8736) 8736
aged (8671) 8671
cyclophosphamide - administration & dosage (8544) 8544
doxorubicin (8217) 8217
animals (8200) 8200
vincristine - administration & dosage (6808) 6808
chemotherapy (5526) 5526
cancer (4907) 4907
antineoplastic combined chemotherapy protocols - administration & dosage (4736) 4736
mice (4453) 4453
doxorubicin - adverse effects (4404) 4404
doxorubicin - therapeutic use (4399) 4399
treatment outcome (4397) 4397
cisplatin - administration & dosage (4021) 4021
combined modality therapy (3994) 3994
prednisone - administration & dosage (3928) 3928
anthracyclines (3894) 3894
antineoplastic combined chemotherapy protocols - adverse effects (3724) 3724
doxorubicin - pharmacology (3564) 3564
breast neoplasms - drug therapy (3439) 3439
pharmacology & pharmacy (3384) 3384
cell line, tumor (3214) 3214
antineoplastic agents - administration & dosage (3104) 3104
antibiotics, antineoplastic - administration & dosage (3053) 3053
prognosis (2939) 2939
adolescent (2935) 2935
drug delivery systems (2785) 2785
methotrexate - administration & dosage (2749) 2749
drug administration schedule (2622) 2622
hematology (2433) 2433
neoplasm staging (2320) 2320
rats (2265) 2265
fluorouracil - administration & dosage (2241) 2241
etoposide - administration & dosage (2207) 2207
survival rate (2197) 2197
physical sciences (2141) 2141
breast cancer (2125) 2125
doxorubicin - pharmacokinetics (2064) 2064
aged, 80 and over (2024) 2024
bleomycin - administration & dosage (2023) 2023
chemistry (1999) 1999
remission induction (1999) 1999
disease-free survival (1986) 1986
retrospective studies (1969) 1969
follow-up studies (1967) 1967
drugs (1951) 1951
care and treatment (1929) 1929
time factors (1921) 1921
tumors (1887) 1887
dose-response relationship, drug (1847) 1847
doxorubicin - analogs & derivatives (1847) 1847
doxorubicin - chemistry (1846) 1846
breast neoplasms - pathology (1774) 1774
survival analysis (1738) 1738
analysis (1702) 1702
science & technology - other topics (1686) 1686
technology (1636) 1636
apoptosis (1619) 1619
drug therapy, combination (1593) 1593
child (1570) 1570
doxorubicin - toxicity (1565) 1565
antineoplastic agents - therapeutic use (1540) 1540
vinblastine - administration & dosage (1517) 1517
materials science (1504) 1504
research (1492) 1492
cell survival - drug effects (1475) 1475
nanoparticles (1470) 1470
chemotherapy, adjuvant (1445) 1445
cyclophosphamide - adverse effects (1404) 1404
neoplasms - drug therapy (1390) 1390
lung neoplasms - drug therapy (1388) 1388
medicine & public health (1384) 1384
prospective studies (1351) 1351
chemistry, multidisciplinary (1344) 1344
apoptosis - drug effects (1324) 1324
liposomes (1310) 1310
mice, inbred balb c (1305) 1305
drug therapy (1287) 1287
health aspects (1284) 1284
lymphoma, non-hodgkin - drug therapy (1280) 1280
antineoplastic agents - pharmacology (1266) 1266
lymphoma, large b-cell, diffuse - drug therapy (1253) 1253
rituximab (1248) 1248
vehicles (1223) 1223
mice, nude (1209) 1209
cyclophosphamide - therapeutic use (1205) 1205
toxicity (1205) 1205
cancer therapies (1204) 1204
drug delivery (1163) 1163
clinical trials as topic (1156) 1156
antibiotics, antineoplastic - pharmacology (1100) 1100
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29625) 29625
Japanese (2285) 2285
German (366) 366
French (342) 342
Chinese (311) 311
Russian (283) 283
Spanish (234) 234
Polish (137) 137
Italian (134) 134
Portuguese (48) 48
Czech (29) 29
Hungarian (29) 29
Ukrainian (15) 15
Dutch (13) 13
Serbian (12) 12
Hebrew (10) 10
Croatian (8) 8
Korean (7) 7
Norwegian (5) 5
Lithuanian (4) 4
Turkish (4) 4
Bulgarian (3) 3
Finnish (3) 3
Persian (3) 3
Danish (2) 2
Romanian (2) 2
Arabic (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 04/2013, Volume 368, Issue 15, pp. 1408 - 1416
A dose-intense infusional chemotherapy program plus rituximab had a high degree of efficacy in patients with primary mediastinal B-cell lymphoma, which is... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Filgrastim | Dose-Response Relationship, Drug | Young Adult | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Kaplan-Meier Estimate | Rituximab | Stroke Volume - drug effects | Etoposide - administration & dosage | Recombinant Proteins - administration & dosage | Disease-Free Survival | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Dose-response relationship (Biochemistry) | Usage | Cyclophosphamide | Patient outcomes | Dosage and administration | Lymphomas | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Doxorubicin | Medical research | Nuclear magnetic resonance--NMR | Disease | Review boards | Genes | Etoposide | Prednisone | Radiation therapy | Kinases | Vincristine | Patients | Morbidity | Chemotherapy | Lymphocytes B | Remission | Mutation | Hodgkin's disease | B-cell lymphoma
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 27, pp. 4199 - 4206
Journal Article
by Horwitz, Steven and O'Connor, Owen A and Pro, Barbara and Illidge, Tim and Fanale, Michelle and Advani, Ranjana and Bartlett, Nancy L and Christensen, Jacob Haaber and Morschhauser, Franck and Domingo-Domenech, Eva and Rossi, Giuseppe and Kim, Won Seog and Feldman, Tatyana and Lennard, Anne and Belada, David and Illés, Árpád and Tobinai, Kensei and Tsukasaki, Kunihiro and Yeh, Su-Peng and Shustov, Andrei and Hüttmann, Andreas and Savage, Kerry J and Yuen, Sam and Iyer, Swaminathan and Zinzani, Pier Luigi and Hua, Zhaowei and Little, Meredith and Rao, Shangbang and Woolery, Joseph and Manley, Thomas and Trümper, Lorenz and Aboulafia, David and Alpdogan, Onder and Ando, Kiyoshi and Arcaini, Luca and Baldini, Luca and Bellam, Naresh and Bartlett, Nancy and Yehuda, Dina Ben and Benedetti, Fabio and Borchman, Peter and Bordessoule, Dominique and Brice, Pauline and Briones, Javier and Caballero, Dolores and Carella, Angelo Michele and Chang, Hung and Cheong, June Weon and Cho, Seok-Goo and Choi, Ilseung and Choquet, Sylvain and Colita, Andrei and Congui, Angela Giovanna and D'amore, Francesco and Dang, Nam and Davison, Kelly and de Guibert, Sophie and Brown, Peter de Nully and Delwail, Vincent and Demeter, Judit and di Raimondo, Francesco and Do, Young Rok and Domingo, Eva and Douvas, Michael and Dreyling, Martin and Ernst, Thomas and Fay, Keith and Ferrero, Silvia Fernandez and Flinn, Ian Winchester and Forero-Torres, Andres and Fox, Christopher and Friedberg, Jonathan and Fukuhara, Noriko and Garcia-Marco, Jose and Cruz, Jorge Gayoso and Codina, Jose Gomez and Gressin, Remy and Grigg, Andrew and Gurion, Ronit and Haioun, Corinne and Hajek, Roman and Hanel, Mathias and Hatake, Kiyohiko and Hensen, Robert and Horowitz, Netanel and Huttmann, Andreas and Illes, Arpad and Ishizawa, Kenichi and Islas-Ohlmayer, Miguel and Jacobsen, Eric and Janakiram, Murali and Jurczak, Wojciech and Kaminski, Mark and Kato, Koji and Kirgner, Ilya and Kuo, Ching-Yuan and Lazaroiu, Mihaela Cornelia and Du, Katell Le and Lee, Jong-Seok and LeGouill, Steven and ... and ECHELON-2 Study Group and ECHELON 2 Study Grp
The Lancet (British edition), ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 229 - 240
Journal Article
The lancet oncology, ISSN 1470-2045, 09/2012, Volume 13, Issue 9, pp. 869 - 878
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 01/2013, Volume 31, Issue 2, pp. 231 - 239
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility - physiology | Fertility Preservation | Young Adult | Vinblastine - adverse effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Oligospermia - epidemiology | Vincristine - administration & dosage | Adult | Female | Gonadotropin-Releasing Hormone - therapeutic use | Hodgkin Disease - physiopathology | Inhibins - blood | Menstrual Cycle - drug effects | Testosterone - blood | Menstrual Cycle - physiology | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - administration & dosage | Ovary - physiology | Hodgkin Disease - epidemiology | Bleomycin - administration & dosage | Bleomycin - adverse effects | Germany - epidemiology | Randomized Controlled Trials as Topic | Pregnancy | Testis - physiology | Hodgkin Disease - blood | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Index Medicus
Journal Article